The chart serves its purpose as a general reminder of each product and where its up to. Not sure about the data for SubB2M prostate cancer or whether they have got that far. BD1's primary focus has been on Breast and Ovarian cancers, with Pancreatic, Prostate and Lung cancers to follow.
I found a great article from Alan Kohler who interviewed our CEO Dr Leearne Hinch below - great insight and worth a read!
Link can't be added - search "eureka report BARD1 life sciences australian biotech success story" and it should come up.
disallowed link/investment-news/bard1-life-sciences-an-australian-biotech-success-story/149386#Early%20detection%20of%20cancers
- Forums
- ASX - By Stock
- IIQ
- Chart Thread
Chart Thread, page-1240
-
- There are more pages in this discussion • 253 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SBW
Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
BM8
Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.0¢ |
Change
0.015(3.09%) |
Mkt cap ! $55.76M |
Open | High | Low | Value | Volume |
47.5¢ | 50.0¢ | 47.5¢ | $47.43K | 97.47K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 107495 | 48.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 7361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 57495 | 0.480 |
3 | 16128 | 0.475 |
2 | 59831 | 0.470 |
2 | 35150 | 0.465 |
2 | 18203 | 0.460 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 7361 | 1 |
0.505 | 28000 | 3 |
0.510 | 20000 | 2 |
0.515 | 25898 | 2 |
0.520 | 10000 | 1 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |